ClinicalTrials.gg
Not yet recruitingNCT07626749AAP-DDKUpdated Jun 4, 2026

DDK Acoustic Analysis and Swallowing Indicators

An observational study in Swallowing Function, Swallowing Risk and Dysphagia, sponsored by Kaohsiung Medical University. Not yet recruiting at 1 site in Taiwan. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by Kaohsiung Medical University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
720
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 45 studies in Deglutition Disorders with a site in Taiwan — 13 open to participants now, 13 under way, none of them phase 3. Deglutition Disorders · Taiwan.

Planned enrollment
Largest of 14
720 · median 49
Started
2026
with 3 others
Observational
14 of 45
5 open now
Primary completion
2030-04
later than 11 of 12 live
Registered
41st of 45
by date

Among the 45 studies in Deglutition Disorders with a site in Taiwan, this one has the largest planned enrollment of the 14 observational ones that give a count, is one of 4 that started in 2026, is one of 14 observational ones, reaches primary completion later than 11 of the 12 other live ones, and was the 41st registered.

Deglutition Disorders

875 studies on the registry are indexed under Deglutition Disorders; 237 are open to participants now.

Browse Deglutition Disorders studies →

Open to participants now

13 of the 45 studies in Deglutition Disorders with a site in Taiwan are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 137 Deglutition Disorders studies recruiting now, 75 (55%) set no upper age limit and 26 (19%) stop at 75 or younger; 15 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 45 studies in Deglutition Disorders with a site in Taiwan, or all of them as a file.
02

Study summary

This study examines whether simple speech tasks and a swallowing screening test can help identify swallowing risk in adults of different ages. Participants will complete basic questions, a swallowing self-assessment, a saliva swallowing test, and short voice recordings of rapid syllables. The study is non-invasive, takes about 75 minutes, and may help develop an easy, low-cost screening tool for early swallowing problems.

Read the detailed description

This is a cross-sectional observational study examining the relationship between diadochokinetic (DDK) speech performance and swallowing function in community-dwelling adults aged 18 years and older. Participants will complete a single study visit, during which demographic and health-related information will be collected, the EAT-10 swallowing self-assessment will be administered, the Repetitive Saliva Swallowing Test (RSST) will be performed, and short DDK speech recordings of /pa/, /ta/, and /ka/ will be obtained in a quiet setting. Acoustic features will be extracted from the recordings and analyzed together with RSST and EAT-10 results to explore age-related differences and to develop a predictive screening model for swallowing risk. All data will be de-identified, securely stored, and retained according to study requirements.

03

Conditions studied

  • Swallowing Function
  • Swallowing Risk
  • Dysphagia

Browse trials for

Keywords

  • Dysphagia
  • Swallowing Function
  • diadochokinetic
  • Acoustic Analysis
  • Repetitive Saliva Swallowing Test
  • EAT-10
  • Older Adults
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of community-dwelling adults aged 18 years and older, with no upper age limit, who are able to communicate in Mandarin or Taiwanese, provide informed consent, and complete DDK tasks, RSST, and EAT-10 assessment. Participants will be recruited from community organizations and related settings in the Kaohsiung-Pingtung region. The study uses a single-visit observational design with age-based subgroup analyses and no intervention.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1.Community-dwelling adults aged 18 years or older, with no upper age limit.
  • 2.Ability to communicate in Mandarin or Taiwanese and understand the study procedures.
  • 3.Willingness to provide written .
  • 4 .Ability to complete the DDK tasks and RSST.

Exclusion criteria

Exclusion Criteria:

  • 1.Presence of acute respiratory infection, upper respiratory inflammation, or other acute conditions that may significantly affect speech or swallowing.
  • 2.Impaired consciousness, significant cognitive deficits, or inability to understand the study procedures.
  • 3.Recent surgery or radiotherapy involving the oral cavity or pharynx that affects speech or swallowing.
  • 4.Severe hearing impairment that prevents understanding of instructions.
  • 5.Any other condition deemed unsuitable for participation by the investigators.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
720 participants (estimated)
Patient registry
No

Groups and cohorts

  • Age-Based Cohort

    Community-dwelling adults aged 18 years and older who complete a single study visit including demographic questionnaire, EAT-10, RSST, and DDK speech recordings. This is an observational cohort with no intervention, and data will be analyzed by age group.

06

What researchers measure

Primary outcomes

  1. Repetitive Saliva Swallowing Test Classification

    Classification of swallowing function based on the Repetitive Saliva Swallowing Test (RSST). Participants will be classified as having normal RSST performance if they complete greater than or equal to 3 swallows in 30 seconds, and abnormal RSST performance if they complete fewer than 3 swallows in 30 seconds.

    Time frame: Day 1

Secondary outcomes

  1. Eating Assessment Tool-10 Total Score

    Total score on the Eating Assessment Tool-10 (EAT-10), a 10-item self-report questionnaire used to assess swallowing-related symptoms. The total score ranges from 0 to 40, where higher scores indicate worse swallowing-related symptoms. A score of 3 or higher suggests possible swallowing difficulty.

    Time frame: Day 1

  2. Diadochokinetic Speech Rate

    Rate of repeated diadochokinetic speech productions of /pa/, /ta/, and /ka/. The rate will be reported as syllables per second.

    Time frame: Day 1

  3. Diadochokinetic Speech Fundamental Frequency

    Fundamental frequency (F0) extracted from repeated diadochokinetic (DDK) speech recordings of /pa/, /ta/, and /ka/. Fundamental frequency will be reported in Hertz (Hz).

    Time frame: Day 1

  4. Diadochokinetic Speech First Formant Frequency

    First formant frequency (F1) extracted from repeated diadochokinetic (DDK) speech recordings of /pa/, /ta/, and /ka/. F1 reflects the first resonance frequency of the vocal tract and will be reported in Hertz (Hz).

    Time frame: Day 1

  5. Diadochokinetic Speech Second Formant Frequency

    Second formant frequency (F2) extracted from repeated diadochokinetic (DDK) speech recordings of /pa/, /ta/, and /ka/. F2 reflects the second resonance frequency of the vocal tract and will be reported in Hertz (Hz).

    Time frame: Day 1

  6. Diadochokinetic Speech Jitter

    Jitter extracted from repeated diadochokinetic (DDK) speech recordings of /pa/, /ta/, and /ka/. Jitter reflects short-term cycle-to-cycle variability in fundamental frequency and will be reported as a percentage.

    Time frame: Day 1

  7. Diadochokinetic Speech Shimmer

    Shimmer extracted from repeated diadochokinetic (DDK) speech recordings of /pa/, /ta/, and /ka/. Shimmer reflects short-term variability in voice amplitude and will be reported in decibels (dB).

    Time frame: Day 1

  8. Diadochokinetic Speech Harmonics-to-Noise Ratio

    Harmonics-to-noise ratio (HNR) extracted from repeated diadochokinetic (DDK) speech recordings of /pa/, /ta/, and /ka/. HNR reflects the ratio of periodic harmonic energy to noise energy in the voice signal and will be reported in decibels (dB).

    Time frame: Day 1

  9. Diadochokinetic Speech Root Mean Square Amplitude

    Root mean square (RMS) amplitude extracted from repeated diadochokinetic (DDK) speech recordings of /pa/, /ta/, and /ka/. RMS amplitude reflects the average acoustic energy of the speech signal and will be reported in normalized amplitude units.

    Time frame: Day 1

  10. Diadochokinetic Speech Zero-Crossing Rate

    Zero-crossing rate (ZCR) extracted from repeated diadochokinetic (DDK) speech recordings of /pa/, /ta/, and /ka/. ZCR reflects the rate at which the speech signal changes sign over time and will be reported as the number of zero crossings per second.

    Time frame: Day 1

Other outcomes

  1. Participant Age

    Age of participants collected at baseline, reported in years.

    Time frame: Day 1

  2. Participant Sex

    Sex of participants collected on Day 1, reported as male or female according to the study case report form.

    Time frame: Day 1

  3. Education Level

    Highest level of education completed by participants collected at baseline, categorized as primary school or below, junior high school, senior high school, or college or above.

    Time frame: Day 1

  4. Body Mass Index

    Body mass index (BMI) calculated from measured height and weight at baseline. Height will be measured in meters and weight in kilograms; BMI will be reported in kg/m².

    Time frame: Day 1

  5. Dentition Status

    Dentition status of participants collected at day 1, categorized as natural dentition, partial denture, full denture, or other.

    Time frame: Day 1

  6. Dry Mouth Frequency

    Self-reported frequency of dry mouth symptoms collected at day 1, categorized as never, occasionally, frequently, or always.

    Time frame: Day 1

  7. Smoking History

    Self-reported smoking history collected at baseline, categorized as never smoker, former smoker, or current smoker.

    Time frame: Day 1

  8. Medical History

    Self-reported medical history collected at day 1 and categorized as none, hypertension, hyperglycemia, hyperlipidemia, or gastrointestinal disease (such as gastroesophageal reflux disease).

    Time frame: Day 1

07

Study locations

1 site
  • Department of Sports Medicine, Kaohsiung Medical University, Taiwan
    Kaohsiung City, Taiwan 807, Taiwan
    • C F HUNG, MASTER · Contactgabino00076@gmail.com · +8867-3121101
    • L Y GUO Professor and Dean of the college of Health Sciences, Doctorate · Contactyuen@kmu.edu.tw · +8867-3121101
    • C F HUNG, Master · Sub investigator
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data collected during the trial, including baseline characteristics, intervention-related measures, and outcome data, will be shared with a data dictionary.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: De-identified individual participant data (IPD) and supporting information will be available starting 2 years after publication of the primary study results and will remain accessible for 5 years.

Access criteria: De-identified individual participant data and related supporting documents will be made available only to qualified researchers affiliated with academic institutions, medical organizations, or public health agencies. Requesters must submit a detailed research proposal and evidence of ethical approval. Access will be granted subject to approval by the study team.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2026; primary completion for Apr 2030, 45 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2026
First posted
Jun 4, 2026
StartEst.
Jun 15, 2026
Primary completionEst.
Apr 9, 2030
CompletionEst.
Apr 9, 2030
Last update
Jun 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07626749
Lead sponsor
Kaohsiung Medical University
Responsible party
Chen-Fu Hung (Principal Investigator, Kaohsiung Medical University) — Principal investigator
First posted
Jun 4, 2026
Start date
Jun 15, 2026 (estimated)
Primary completion
Apr 9, 2030 (estimated)
Completion
Apr 9, 2030 (estimated)
Last update
Jun 4, 2026

Study contacts

HUNG C F Kaohsiung Medical University, MASTER
Contact
gabino00076@gmail.com
+8867-3121101 ext. #2646 #614
GUO L Y Professor and Dean of the College of Health Sciences, Departme, Ph. D.
study chair · Department of Sports Science, Kaohsiung Medical University, Taiwan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion